Skip to main content
. 2023 Oct 13;62(24):3699–3706. doi: 10.2169/internalmedicine.2551-23

Figure 3.

Figure 3.

Gadolinium-based contrast-enhanced brain magnetic resonance imaging findings. A: An abnormal signal was evident in the left cisternal trigeminal region (arrow) and the left third branches of the trigeminal region (arrowheads) on T1-weighted imaging before treatment. B: Contrast effects in the trigeminal region decreased after 80 days of treatment.